Spots Global Cancer Trial Database for gastrooesophageal cancer

Every month we try and update this database with for gastrooesophageal cancer cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization
Chemotherapy for Patients With Gastroesophageal Cancers Who Have Progressed After One Prior Chemo Regimen	NCT01365130	Esophageal Gastrooesophage... Gastric Cancer	jevtana	18 Years -	Brown University
Tusamitamab Ravtansine (SAR408701) in Combination With Ramucirumab in Pretreated Participants With Gastric Cancer	NCT05071053	Adenocarcinoma ... Gastrooesophage...	Ramucirumab (CY... Tusamitamab rav...	18 Years -	Sanofi
Proof-of-concept Study of Ibrutinib in c-MYC and HER2 Amplified Oesophagogastric Carcinoma	NCT02884453	Gastrooesophage...	ibrutinib	18 Years -	Royal Marsden NHS Foundation Trust
Esophageal Stump Washout	NCT01980394	Esophageal Canc... Gastrooesophage...	Esophageal Stum...	18 Years - 95 Years	Kantonsspital Liestal
Chemotherapy for Patients With Gastroesophageal Cancers Who Have Progressed After One Prior Chemo Regimen	NCT01365130	Esophageal Gastrooesophage... Gastric Cancer	jevtana	18 Years -	Brown University
Trial of Afatinib in Combination With Weekly Paclitaxel in the Second Line Treatment	NCT02274012	HER-2 Positive ... Gastrooesophage... Esophageal Canc...	Afatinib Paclitaxel	18 Years -	Columbia University
Proof-of-concept Study of Ibrutinib in c-MYC and HER2 Amplified Oesophagogastric Carcinoma	NCT02884453	Gastrooesophage...	ibrutinib	18 Years -	Royal Marsden NHS Foundation Trust
B-Receptor Signaling in Cardiomyopathy	NCT01135849	Carcinomas Amyloidosis Anal Cancer Anemia Cholangiocarcin... Transitional Ce... Bone Marrow Tra... Bone Cancer Cancer of Brain... Breast Cancer Carcinoma of th... Endocrine Cance... Esophageal Canc... Eye Cancer Gall Bladder Ca... Gastric (Stomac... Gastrooesophage... Gastrointestina... Gynecologic Can... Head and Neck C... Hepatobiliary N... Kidney (Renal C... Leukemia Lung Cancer Hodgkin Disease Lymphoma, Non-H... Mesothelioma Multiple Myelom... Myelodysplastic... Neuroendocrine ... Myeloproliferat... Pancreatic Canc... Prostate Cancer Skin Cancer Soft Tissue Sar... Testicular Canc... Thymus Cancer Thyroid Cancer		- 40 Years	Stanford University
A Multicenter Open-label Phase II Trial to Evaluate Nivolumab and Ipilimumab for 2nd Line Therapy in Elderly Patients With Advanced Esophageal Squamous Cell Cancer	NCT03416244	Esophageal Canc... Oesophageal Can... Oesophageal Can... Esophageal Canc... Esophageal Canc... Oesophageal Can... GastroEsophagea... Gastrooesophage...	Nivolumab Ipilimumab	65 Years -	AIO-Studien-gGmbH
A Multicenter Open-label Phase II Trial to Evaluate Nivolumab and Ipilimumab for 2nd Line Therapy in Elderly Patients With Advanced Esophageal Squamous Cell Cancer	NCT03416244	Esophageal Canc... Oesophageal Can... Oesophageal Can... Esophageal Canc... Esophageal Canc... Oesophageal Can... GastroEsophagea... Gastrooesophage...	Nivolumab Ipilimumab	65 Years -	AIO-Studien-gGmbH
B-Receptor Signaling in Cardiomyopathy	NCT01135849	Carcinomas Amyloidosis Anal Cancer Anemia Cholangiocarcin... Transitional Ce... Bone Marrow Tra... Bone Cancer Cancer of Brain... Breast Cancer Carcinoma of th... Endocrine Cance... Esophageal Canc... Eye Cancer Gall Bladder Ca... Gastric (Stomac... Gastrooesophage... Gastrointestina... Gynecologic Can... Head and Neck C... Hepatobiliary N... Kidney (Renal C... Leukemia Lung Cancer Hodgkin Disease Lymphoma, Non-H... Mesothelioma Multiple Myelom... Myelodysplastic... Neuroendocrine ... Myeloproliferat... Pancreatic Canc... Prostate Cancer Skin Cancer Soft Tissue Sar... Testicular Canc... Thymus Cancer Thyroid Cancer		- 40 Years	Stanford University

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

Join others from around the world: